Ceftazidime–avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections
Philippe Lagacé‐Wiens(Manitoba Health), James A. Karlowsky(University of Manitoba)
Cited by 166
Related Papers
Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of <i>Escherichia coli</i> from Female Outpatients in the United States
|Antimicrobial Agents and Chemotherapy|2002|369
Surveillance for Antimicrobial Susceptibility among Clinical Isolates of <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii</i> from Hospitalized Patients in the United States, 1998 to 2001
|Antimicrobial Agents and Chemotherapy|2003|352
Multidrug-Resistant Urinary Tract Isolates of <i>Escherichia coli:</i> Prevalence and Patient Demographics in the United States in 2000
|Antimicrobial Agents and Chemotherapy|2001|299
Emerging resistance among bacterial pathogens in the intensive care unit – a European and North American Surveillance study (2000–2002)
|Annals of Clinical Microbiology and Antimicrobials|2004|272